secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2024-04-30T23:59:59+00:00
Accession:  0001104659-24-054910
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Immunome VP Finance/PAO Bob Lapetina resigns; Max Rosett named PAO effective May 10
--------------------------------------------------------------------------------

- Bob Lapetina resigned as VP Finance, Corporate Controller and principal accounting officer effective May 10, 2024; departure not due to disagreement.
- Max Rosett appointed principal accounting officer effective May 10, 2024; he currently serves as Interim CFO, EVP Operations since December 2023.
- Rosett previously held roles at Morphimmune and Research Bridge Partners; no new material plan or contract entered in connection with appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924054910/0001104659-24-054910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465924054910/tm2413152d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-054910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer